ALEXA THOMAS DECK: Open Payments
NPI 1750929295 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,361 in 50 payments from 16 companies in 2025. Trend: 2023 $2,548 · 2024 $2,598 · 2025 $1,361
Food & beverage: $1,281Education: $80
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 16 | $225 |
| ABBVIE INC. | 5 | $200 |
| Galderma Laboratories, L.P. | 2 | $188 |
| Organon LLC | 6 | $173 |
| Janssen Scientific Affairs, LLC | 1 | $123 |
| Janssen Biotech, Inc. | 4 | $106 |
| UCB, Inc. | 4 | $78 |
| PFIZER INC. | 3 | $63 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $44 |
| Botanix SB Inc | 2 | $35 |
Products named: TREMFYA, Zoryve, NEMLUVIO, RINVOQ, VTAMA, Bimzelx, SKYRIZI, CIBINQO.
Industry payments across GA — which companies pay providers there.
